Download Text Only (.pdf) Version of BCG Bulletin

The BCG Bulletin                            

The Official Newsletter of the Biologics Consulting Group, Inc.

 

Issue 35

January 14, 2008

 

Bulletin Highlights

BCG Welcomes Dr. Janice Wilson & Dr. Nebojsa Djordjevic

Spotlight on Outsourcing

An Early Look at FDA Regulation of Nanotechnology

The Proof-of-Principle Alliance

Your chance to meet with BCG representatives

 
Featured Stories

BCG Welcomes:
Janice M. Wilson, Ph.D.
Nebojsa M. Djordjevic, Ph.D.

JANICE M. WILSON, PH.D.

Dr. Wilson joined the group in December 2007. She is a quality and compliance executive with over 25 years of global and international experience in the highly regulated bioscience industries. Dr. Wilson was most recently the Global Head of Compliance for Novartis Vaccine and Diagnostics working out of the Emeryville, CA office where she was a member of the executive team providing oversight for the development and implementation of the division's Quality Manual. Her experience includes development, implementation, and directing of sustainable Quality Systems, Quality Assurance programs, and extensive Regulatory Compliance programs for GMP and ISO activities.

Read Announcement

See Curriculum Vitae


NEBOJSA M. DJORDJEVIC, PH.D.

Dr. Djordjevic joined BCG in January of 2008. Dr. Djordjevic has over 20 years of experience in Analytical Chemistry utilized in Pharmaceutical and Biopharmaceutical Industry. During this time he has played an active role at virtually every phase of drug development from target identification, lead identification, compound selection and characterization, and pharmaceutical product development. He was most recently the Director of Analytical Chemistry at Cytokinetics Inc., a biopharmaceutical company involved in the discovery and development of oncology and cardiovascular drugs.

Read Announcement

See Curriculum Vitae

 

Spotlight on Outsourcing
Articles by
Michael Trapani, MS, MBA & David Pepperl, Ph.D.
Senior Consultants

The November issue of RAPS Focus Magazine highlights Outsourcing and includes contributions by both Michael Trapani, MS, MBA and David Pepperl, Ph.D.

Quality & Compliance: The Quality Agreement
Michael Trapani, MS, MBA
Contact Mr. Trapani...

Preclinical Outsourcing in 2008: Key Considerations for Study Success
David Pepperl, Ph.D.
Contact Dr. Pepperl...

An Early Look at FDA Regulation of Nanotechnology
Article by
Stuart Portnoy, M.D., Sr. Medical Device Consultant
Nanotechnology, broadly defined, is the field of applied science whose unifying theme is the fabrication of materials and products on the atomic and molecular scale -- normally 1 to 100 nanometers (nms). There is currently a wellspring of academic and private sector research and development exploring the myriad potentials for nanotechnology to provide enhanced performance of existing technologies (e.g., improved efficiency of photovoltaic cells) and to offer novel solutions to historically vexing problems (e.g., targeting chemotherapy drugs for release at tumor sites while sparing healthy tissues).

Nanomedicine

Nanomedicine is an area of biomedical research that seeks to use nanoscale tools to improve health. Current medical uses of nanotechnology include sunscreens, dental-bonding agents, novel wound dressings, and liposomal drug delivery platforms.

Continue Reading....

Contact Dr. Portnoy...

The Proof-of-Principle (POP) Alliance


Biologics Consulting Group, Inc (BCG) has partnered with AVOS Life Sciences to create the Proof-of-Principle Alliance (POP Alliance) to provide fast track product development and commercialization/valuation consulting services to early phase biopharmaceutical companies seeking to accelerate the advancement of their products from the research and development phase through a proof-of-principle clinical trial. See www.POPAllianceUSA.com for additional information.

Upcoming BCG Presentations
& Conference Appearances

BCG consultants attend numerous conferences every year during which they are available to provide company information or consulting expertise. Below are some conferences that BCG consultants will be attending in the near future. Please feel free to contact the attending consultant either before, or during the conference for company information or to discuss a business opportunity.

Date
Sponsoring Organization
Conference and Presentation Title
BCG Attendee(s)/ Speaker (s)
Location
January 14 - 15, 2008 IBC China US FDA Biological Approval Process Lei Zhang, MD, Ph.D.
(speaker)
Seoul, South Korea
January 14 - 16, 2008 ALS Association ALSA Research Workshop Wilson W. Bryan, M.D.
(speaker)
Tampa, FL
January 17 - 18, 2008 IBC China US FDA Biological Approval Process Lei Zhang, MD, Ph.D.
(speaker)
Taipei, Taiwan
January 21-23, 2008 Institute for International Research

5th Annual Formulation & Forced Degradation

"Implementation of a flexible yet cGMP complaint Stability Program for Phase I, II and III Studies"

Nanda Subbaro, Ph.D.
(speaker)
San Diego, CA
January 27-30, 2008 CASSS

CMC Strategy Forum

Current Practices for Assessing the Comparability and Stability of Gene Therapy Products

Andra Miller, Ph.D.
Maritza C. McIntyte, Ph.D.

Nadine Ritter, Ph.D.
(co-leader)
Darin Weber, Ph.D.
Washington, DC
January 27-30, 2008 CASSS

CMC Strategy Forum

Extractables and Leachables: Challenges and Strategies in Biopharmaceutical Development

Keith Wells, Ph.D.
Ruth Wolff, Ph.D.
Washington, DC
January 27-30, 2008 CASSS

CMC Strategy Forum

12th Annual Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products

Nadine Ritter, Ph.D.
(speaker)
Keith Wells, Ph.D.
Ruth Wolff, Ph.D.
Washington, DC
January 28-29, 2008 International Pharamceutical Academy (IPA)

FDA Pre-Approval Inspections

"FDA approval processes and combination device and biologics inspections"

John R. Godshalk, MSE, MBA
(speaker)
Toronto, Canada
January 28-30, 2008 Phacilitate Phacilitate Cell & Gene Therapy Forum 2008 Andra Miller, Ph.D.
Maritza C. McIntyte, Ph.D.

Darin Weber, Ph.D.
Washington DC
February 9-10, 2008 ISCTR (International Society for Cardiovascular Translational Research)

Annual Meeting

"Regulatory Considerations for Cell Manufacturing and Cell Delivery"

Darin Weber, Ph.D.
(speaker)
San Diego, CA
February 21-22, 2008 Texas Scottish Rite Hospital for Children 30th Annual Carrell-Krusen Neuromuscular Symposium Wilson W. Bryan, M.D. Dallas, TX
February 25-29, 2008 Seton Hall Law School

Health Care Compliance Certification Program

"Advertising & Promotion of Medical Devices"

Stuart Portnoy, MD
(speaker)
Newark, NJ
March 6-7, 2008 ASENT (American Society of Experimental NeuroTherapeutics) Annual Meeting Wilson W. Bryan, MD
(course co-director)
Washington, DC
March 16-20, 2008 Society of Toxicology SOT Annual Meeting and Tox Expo John Jessop, Ph.D., MPH Seattle, WA
March 28-29, 2008 AABB
(American Association of Blood Banks)

Spring Conference 2008

Regulatory Considerations of Using Stem Cells for Cardiac Applications

Ellen M. Areman, MS, SBB
(speaker)
Orlando, FL
Contact Us:
 
Alexandria, Virginia

Main Office - Alexandria, Virginia

 

North Carolina Office

West Coast Office

New England Office

Beijing Office

 

BCG services overview:

  • Regulatory Advice
  • Regulatory Submissions
  • Compliance issues
  • "Mock" FDA Inspections
  • Pharmacology/ Toxicology Review
  • Clinical Development Planning and Regulatory Advice
  • Process Development/ Process Validation
  • Comprehensive preclinical product development
  • SOP Preparation
  • Quality Systems Assessment
  • Project Management
  • Training
  • US Agent Services
  • View BCG's List of Expertise

View Archived Newsletters

Like What You See?

Subscribe a Friend

Links on BCG Web Site:

About BCG ~ Staff ~ Services ~ Rates ~ Contact Us ~ Regulatory Library ~ Useful Web Links

 

Copyright © 2000-2001 RiderWeb, Inc.